{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Neurología/Clinical practice/Clinical Reasoning/Schreck et al. - 2015 - Clinical Reasoning A 44-year-old woman with rapid.pdf",
  "fileName": "Schreck et al. - 2015 - Clinical Reasoning A 44-year-old woman with rapid.pdf",
  "relativePath": "Neurología/Clinical practice/Clinical Reasoning/Schreck et al. - 2015 - Clinical Reasoning A 44-year-old woman with rapid.pdf",
  "text": "RESIDENT\n              & FELLOW\n              SECTION\n                         Clinical Reasoning:\nSection Editor           A 44-year-old woman with rapidly\nMitchell S.V. Elkind,\nMD, MS                   progressive weakness and ophthalmoplegia\n\nKarisa C. Schreck, MD,   SECTION 1                                                                          79–90, blood pressure range 120–140/70–85 mm\n  PhD                    A 41-year-old woman with active IV and subcutaneous                                Hg, pulse oximetry 97%–99%, with FiO2 of 0.4.\nLogan Schneider, MD      heroin use complicated by recurrent methicillin-                                   She was alert and fully oriented, unable to speak\nRomergryko G.            resistant Staphylococcus aureus endocarditis presented                             due to weakness (endotracheal tube in place), and\n  Geocadin, MD           to the emergency department with 2 days of progress-                               answering yes-no with faint hand movements.\n                         ive dyspnea. Two days prior to presentation, she had 2                             Otherwise, her strength was 0/5 per Medical Research\n                         episodes of vomiting and one of diarrhea, but no head-                             Council scale. She had complete bilateral ptosis and\nCorrespondence to        ache, fever, chills, weakness, numbness, or confusion.                             mydriatic, reactive pupils. Eye movements were lim-\nDr. Schreck:\nksolt1@jhmi.edu\n                         While in the emergency department, she developed                                   ited in all cardinal directions. She was areflexic except\n                         hypoxic respiratory failure requiring intubation and                               for trace reflexes in the patellar tendon bilaterally; toes\n                         was admitted to the medical intensive care unit.                                   were mute. Sensation was grossly intact.\n                             The next day, upon weaning sedation for planned\n                                                                                                            Questions for consideration:\n                         extubation, the patient was unable to open her eyes or\n                         move her limbs. Spontaneous breathing trials failed                                1. Where would you localize this patient’s rapidly\n                         when the patient became tachypneic with tidal vol-                                    progressive, generalized weakness?\n                         umes reaching 70 mL. On examination, her vital                                     2. What is the differential diagnosis for a patient with\n                         signs were notable for normothermia, heart rate                                       rapidly progressive weakness and ophthalmoplegia?\n\n\n\n\n                                                                                                                                                            GO TO SECTION 2\n\n\n\n\n                         From the Departments of Neurology (K.C.S., R.G.G.) and Anesthesiology/Critical Care Medicine (R.G.G.), Johns Hopkins University, Baltimore,\n                         MD; and the Department of Neurology (L.S.), Stanford University, CA.\n                         Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.\n\ne22                      © 2015 American Academy of Neurology\n\n   ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                                                                                SECTION 2\n                    Table        Differential diagnosis for rapidly\n                                 progressive weakness\n                                                                                Rapidly progressive weakness can localize to many\n                                                                                areas. In this patient, ophthalmoplegia and facial\n                    Acute inflammatory demyelinating polyneuropathy             weakness with intact mental status helps narrow the\n                    (especially Miller Fisher syndrome or Bickerstaff\n                    encephalitis)                                               localization to brainstem, nerves, or neuromuscular\n                    Myasthenia gravis                                           junction.\n                    Lambert-Eaton myasthenic syndrome\n                                                                                   The differential diagnosis for rapidly progress-\n                                                                                ive weakness with ophthalmoplegia is relatively\n                    Botulism\n                                                                                limited (table). The striking features on examina-\n                    Brainstem stroke\n                                                                                tion were rapid decompensation along with nearly\n                    CNS infections (particularly of brainstem)\n                                                                                absent reflexes and prominent bulbar symptoms.\n                    Poliomyelitis                                               The initial concern was for acute inflammatory\n                    West Nile virus infection                                   demyelinating polyneuropathy (AIDP), possibly\n                    Tick paralysis                                              due to HIV given her history of IV drug use.1\n                    Saxitoxin (paralytic shellfish poisoning)\n                                                                                Another consideration was a myasthenia gravis\n                                                                                (MG) crisis. In a patient consuming questionable\n                    Tetrodotoxin (puffer fish poisoning)\n                                                                                food products or with a history of heroin abuse,\n                    Streptococcal pharyngitis\n                                                                                botulism toxicity was a consideration. The pa-\n                    Diphtheria                                                  tient’s complaints of abdominal pain, vomiting,\n                    Acute intermittent porphyria                                and diarrhea preceding presentation made acute\n                    Hyperemesis gravidarum                                      intermittent porphyria a possibility.\n                    Inflammatory myopathy                                       Question for consideration:\n                    Critical illness neuromyopathy (rarely affects the bulbar\n                    muscles)                                                    1. What diagnostic evaluation should be performed\n                    Intoxication with CNS depressants (atropine,\n                                                                                   in this patient?\n                    aminoglycoside, magnesium, ethanol, organophosphates,\n                    nerve gas, carbon monoxide)\n\n                    Psychiatric illness (conversion paralysis)\n\n\n\n\n                                                                                                               GO TO SECTION 3\n\n\n\n\n                                                                                Neurology 85   July 21, 2015                   e23\n\nª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    SECTION 3                                                the following: 1 leukocyte per mm3, 1 erythrocyte per\n                    EMG with nerve conduction studies (NCS) of radial,       mm3, glucose 99 mg/dL (serum 168 mg/dL), protein\n                    median, ulnar, and sural nerves showed normal sen-       26 mg/dL. Venereal disease research laboratory, cryp-\n                    sory nerve action potential (SNAP) amplitudes and        tococcal antigen, fungal culture, viral PCRs (herpes\n                    conduction velocities. Motor responses had normal        simplex virus, varicella-zoster virus, West Nile virus,\n                    amplitudes, latencies, conduction velocities, and        cytomegalovirus, Epstein-Barr virus, and enterovirus),\n                    F-waves. Motor unit action potentials (MUAP) were        immunoglobulin G index, and oligoclonal bands were\n                    absent in proximal muscles, but present in the distal    all negative. An MRI of the brain and cervical spine was\n                    muscles, though they tended to be small and short        unremarkable. A thorough skin evaluation was only\n                    in duration. There were widespread sharp waves           notable for track marks on bilateral forearms.\n                    and fibrillations.\n                                                                             Questions for consideration:\n                       Initial laboratory testing including serum creatine\n                    kinase, heme-8, C-reactive protein, and chemistry        1. What treatment should be pursued?\n                    panel was unremarkable. A lumbar puncture revealed       2. Is further diagnostic testing indicated?\n\n\n\n\n                                                                                                               GO TO SECTION 4\n\n\n\n\ne24                 Neurology 85   July 21, 2015\n\n  ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                  SECTION 4                                                    Samples of the patient’s pre-IVIg-administration serum\n                  The patient was empirically administered IV immu-            and stool were sent to the health department for testing\n                  noglobulin (IVIg 0.4 g/kg/day for 5 days) on presen-         and she was administered the quadrivalent botulinum\n                  tation over concern for AIDP, achieving minimal              immunoglobulin on day 6 of hospitalization.\n                  improvement in symptoms. An expanded panel of                   To confirm our diagnosis of botulism, follow-up\n                  laboratory studies and delayed results from initial in-      EMG/NCS was performed, revealing decreased com-\n                  vestigations (including GQ1b-Ab, AChR-Ab, MusK,              pound motor action potential (CMAP) amplitudes as\n                  urine porphobilinogen, HIV antibodies, viral hepati-         compared to previous results. Distal latencies, con-\n                  tis serologies, Lyme antibodies, heavy metals, thyroid       duction velocities, and F-wave latencies remained\n                  function tests, aldolase, and plasma catecholamines)         normal. Repetitive stimulation was performed at 3\n                  were notable only for a moderately elevated erythrocyte      Hz with no decrement of 10% or more (figure, A).\n                  sedimentation rate at 66 mm/hour. Since a lumbar             Rapid repetitive stimulation was performed at 50 Hz,\n                  puncture is only 50% sensitive for cytoalbuminologic         with no increment (figure, B). EMG of multiple\n                  dissociation in the first week of symptoms but increases     muscles showed positive sharp waves, fibrillation\n                  to 75% by the third week,2 a repeat lumbar puncture          potentials, and few units with poor activation.\n                  was performed, also showing a normal profile.\n                                                                               Question for consideration:\n                      Based on the negative clinical workup, lack of cytoal-\n                  buminologic dissociation, and minimal response to IVIg,      1. Are the EMG/NCS findings consistent with a\n                  the clinical picture was concerning for acute botulism.         diagnosis of botulism?\n\n\n\n\n                                                                                                                  GO TO SECTION 5\n\n\n\n\n                    Figure      Repetitive nerve stimulation of trapezius\n\n\n\n\n                  Repetitive nerve stimulation of trapezius shows (A) no decrement at 3 Hz and (B) no increment at 50 Hz.\n\n                                                                               Neurology 85   July 21, 2015                        e25\n\nª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    SECTION 5                                              and EMG/NCS were most consistent with a diagno-\n                    The repeat EMG/NCS study showed abnormal               sis of botulism. The classic findings on electrodiag-\n                    spontaneous activity, decreased motor activation,      nostic studies in botulism are decreased amplitude\n                    and myopathic motor unit potentials (decreased size    in MUAPs with facilitation at 20–50 Hz using\n                    and duration of motor units). The sensory nerves re-   repetitive stimulation.3 Of note, facilitation with\n                    mained normal; however, the motor nerves had           repetitive stimulation is only seen in 50%–60% of\n                    developed decreased CMAP amplitudes without evi-       patients, and it is typically less dramatic than in\n                    dence of demyelination (normal distal latencies,       Lambert-Eaton myasthenic syndrome.4\n                    conduction velocities, and F-waves). This pattern\n                                                                           Question for consideration.\n                    suggested a myopathic or neuromuscular junction\n                    disorder. The clinical history, normal creatine        1. What evaluations can be used to confirm a diag-\n                    kinase, bulbar-predominant pattern of weakness,           nosis of botulism?\n\n\n\n\n                                                                                                           GO TO SECTION 6\n\n\n\n\ne26                 Neurology 85   July 21, 2015\n\n  ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                  SECTION 6                                                      a CT followed by MRI (time permitting) to rule out\n                  The diagnosis of botulism is made using a mouse                brainstem pathologies, a lumbar puncture to investigate\n                  inoculation assay. Serum or stool samples from                 CNS infections vs AIDP, and standard serologic studies\n                  affected individuals are injected into mice along with         focused on precipitants of acute infectious etiologies such\n                  toxin type-specific antitoxin. Symptoms develop in             as HIV,1 diphtheria, and polio.\n                  mice without the antitoxin against the specific toxin              Botulinum toxin is extremely potent and irreversibly\n                  type the affected individual carries. The assay is             cleaves SNAP-SNARE-complex proteins, important\n                  dependent on the presence of active botulinum toxin            facilitators of vesicle fusion at the synaptic membrane,\n                  and most sensitive within 24 hours of presentation,            thereby preventing synaptic vesicle release. Antitoxin\n                  but can still be positive up to 7 days after presenta-         binds free toxin and prevents it from inactivating fur-\n                  tion. Overall sensitivity is low (33%–46%).3,5 Stool           ther synapses. Due to the potency of botulinum toxin,\n                  can also be cultured for the organism, which increases         antitoxin should be empirically administered immedi-\n                  sensitivity to ;70%.3 In our patient, the mouse inoc-          ately if the clinical suspicion is high though clinical trial\n                  ulation assay was negative; however, mass spectros-            data are scarce.8 Currently, mortality is relatively low at\n                  copy on the serum sample was positive for botulinum            3%–5%,6 but there is often a long invalid period with\n                  toxin, type A.                                                 average intubation lasting 2–8 weeks.9 Patients often\n                      Our patient survived 2 ventilator-associated pneu-         recover completely if they survive the initial high-risk\n                  monias and a urinary tract infection before being              ventilated period. However, it is a slow recovery process\n                  weaned off the ventilator and percutaneous tube                and some patients still have exercise limitations and\n                  feeds. Four months after her admission, she was able           subjective shortness of breath years after diagnosis.\n                  to ambulate independently and care for herself. She\n                  continues to make gains in strength and endurance.             AUTHOR CONTRIBUTIONS\n                                                                                 Dr. Karisa Schreck analyzed and interpreted the data, conceptualized the\n                                                                                 case, and wrote the manuscript. Dr. Logan Schneider analyzed and inter-\n                  DISCUSSION Clostridium botulinum is a Gram-                    preted the data and wrote the manuscript. Dr. Romergryko G. Geocadin\n                  positive, anaerobic, spore-forming bacillus. Currently,        analyzed the case and revised the manuscript for intellectual content.\n                  there are 7 toxin types (A–G), though human botulism\n                  is primarily caused by A, B, and E. The most common            ACKNOWLEDGMENT\n                                                                                 The authors thank Dr. Thomas Lloyd, Johns Hopkins University, for\n                  form is infant botulism (71%), then foodborne (24%),\n                                                                                 assistance with electrodiagnostic studies; Jenie Morris, CDC; and David\n                  and wound (3%).6 Symptoms typically begin 18–36                Blythe and David Schnavel, Maryland Health Department.\n                  hours after exposure for foodborne botulism and 4–14\n                  days after exposure for wound botulism.3 In foodborne          STUDY FUNDING\n                  botulism, preformed toxin is consumed—causing early            Dr. Geocadin is supported in part by NIH grant RO1HL071568.\n                  symptoms of nausea, vomiting, and diarrhea—while in\n                                                                                 DISCLOSURE\n                  wound botulism, the organism grows within a wound\n                                                                                 The authors report no disclosures relevant to the manuscript. Go to\n                  and produces toxin. An increased frequency of wound            Neurology.org for full disclosures.\n                  botulism was seen several years ago attributed to the\n                  popularity of skin popping (subcutaneous injection of          REFERENCES\n                  heroin) with an impure form of heroin known as black           1. Brannagan TH, Zhou Y. HIV-associated Guillain-Barre\n                  tar heroin.7 Our patient had prominent track marks and            syndrome. J Neurol Sci 2003;208:39–42.\n                                                                                 2. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of\n                  subcutaneous granulomas on both of her forearms from\n                                                                                    anti-GQ1b IgG antibody testing in Fisher syndrome com-\n                  IV drug use and intermittent skin popping, which was              pared with cerebrospinal fluid examination. J Neuroimmunol\n                  likely the source of her exposure.                                2004;148:200–205.\n                      The most common clinical presentation of botulism          3. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the\n                  is early cranial nerve abnormalities, gastrointestinal symp-      United States: a clinical and epidemiologic review. Ann\n                  toms, and autonomic symptoms (dry mouth, blurred                  Intern Med 1998;129:221–228.\n                                                                                 4. Maselli RA, Bakshi N. Botulism. Muscle Nerve 2000;23:\n                  vision, bradycardia) without the characteristic volatile\n                                                                                    1137–1144.\n                  dysautonomia of AIDP, followed by a descending paral-          5. Sobel J. Botulism. Clin Infect Dis 2005;41:1167–1173.\n                  ysis. Ophthalmoparesis with dilated pupils that are fixed      6. Health SFDoP. Botulism. San Francisco: Health SFDoP;\n                  or poorly reactive is present in about half of patients with      2008:11.\n                  botulism. Early differentiation of botulism from other         7. Passaro DJ, Werner SB, McGee J, Mac Kenzie WR,\n                  neurologic emergencies such as AIDP or MG can be                  Vugia DJ. Wound botulism associated with black tar heroin\n                                                                                    among injecting drug users. JAMA 1998;279:859–863.\n                  challenging, and the emphasis should be stabilization\n                                                                                 8. Chalk CH, Benstead TJ, Keezer M. Medical treatment for\n                  in a critical care setting while undertaking an expedited\n                                                                                    botulism. Cochrane Database Syst Rev 2014;2:CD008123.\n                  diagnostic evaluation focusing on early therapeutic inter-     9. Vasa M, Baudendistel TE, Ohikhuare CE, et al. Clinical\n                  vention. The initial investigations should include a thor-        problem-solving: the eyes have it. N Engl J Med 2012;367:\n                  ough physical examination, electrodiagnostic studies,             938–943.\n\n                                                                                 Neurology 85      July 21, 2015                                   e27\n\nª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f  Clinical Reasoning: A 44-year-old woman with rapidly progressive weakness and\n                                  ophthalmoplegia\n           Karisa C. Schreck, Logan Schneider and Romergryko G. Geocadin\n                              Neurology 2015;85;e22-e27\n                        DOI 10.1212/WNL.0000000000001761\n\n                        This information is current as of July 20, 2015\n\n Updated Information &              including high resolution figures, can be found at:\n Services                           http://www.neurology.org/content/85/3/e22.full.html\n\n References                         This article cites 8 articles, 1 of which you can access for free at:\n                                    http://www.neurology.org/content/85/3/e22.full.html##ref-list-1\n Subspecialty Collections           This article, along with others on similar topics, appears in the\n                                    following collection(s):\n                                    All Education\n                                    http://www.neurology.org//cgi/collection/all_education\n                                    All Infections\n                                    http://www.neurology.org//cgi/collection/all_infections\n                                    Critical care\n                                    http://www.neurology.org//cgi/collection/critical_care\n                                    EMG\n                                    http://www.neurology.org//cgi/collection/emg\n                                    Other toxicology\n                                    http://www.neurology.org//cgi/collection/other_toxicology\n Permissions & Licensing            Information about reproducing this article in parts (figures,tables) or in\n                                    its entirety can be found online at:\n                                    http://www.neurology.org/misc/about.xhtml#permissions\n Reprints                           Information about ordering reprints can be found online:\n                                    http://www.neurology.org/misc/addir.xhtml#reprintsus\n\n\n\n\nNeurology ® is the official journal of the American Academy of Neurology. Published continuously since\n1951, it is now a weekly with 48 issues per year. Copyright © 2015 American Academy of Neurology. All\nrights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.",
  "wordCount": 2282,
  "indexed": "2025-09-25T22:55:04.624Z",
  "method": "direct"
}
